That paper with the ‘T’ error bars was just retracted

Remember the paper that made the rounds on Twitter after readers discovered that the error bars in one of its figures were really just capital Ts? 

Well, it’s now been retracted, with the notice citing “concerns about the article’s scientific reliability.” 

Error bars are supposed to express the statistical uncertainty of a measurement depicted in a graph, but the ones in this paper appeared to be capital letter Ts pasted on for looks. 

As we mentioned in a previous post, the error bars were just the most obvious strange thing about the paper, “Monitoring of Sports Health Indicators Based on Wearable Nanobiosensors,” which was published earlier this year in a special issue of the Hindawi journal Advances in Materials Science and Engineering

Continue reading That paper with the ‘T’ error bars was just retracted

Contamination leads to swift retraction for Science paper on the origins of Omicron in Africa

The authors of a paper that proposed the Omicron variant of SARS-Cov-2 had evolved in Western Africa months before it was first detected in South Africa have retracted their study after discovering contamination in their samples, as several scientists had suggested on Twitter was the case. 

The article, “Gradual emergence followed by exponential spread of the SARS-CoV-2 Omicron variant in Africa,” was published in Science on December 1 by a team led by Jan Felix Drexler of Charité – Universitätsmedizin Berlin. 

Soon after publication, many geneticists expressed skepticism on social media about the study, including questioning whether the results came from contamination during the sequencing process. 

Tulio de Oliveira, director of the Centre for Epidemic Response and Innovation and the KwaZulu-Natal Research Innovation and Sequencing Platform at the University of KwaZulu-Natal in South Africa, tweeted on December 4 about “weaknesses” in the study, including that “the quality of the sequences seems problematic”: 

Continue reading Contamination leads to swift retraction for Science paper on the origins of Omicron in Africa

Article on sexual orientation and psych disorders retracted – without the author’s knowledge, he says

Dick Swaab

A paper about the potential influence of neurotransmitters on the development of sexual orientation and psychiatric disorders that caught flack on social media a year ago has now been retracted – so recently that the corresponding author said he didn’t know about the retraction until we asked him about it. 

Late last year, Neuroscience & Biobehavioral Reviews, an Elsevier journal, published an expression of concern for the article “Sexual orientation, neuropsychiatric disorders and the neurotransmitters involved.” It was published online in September 2021 and has not been cited, according to Clarivate’s Web of Science. 

The notice said only that “some readers have raised concerns” about the article, which the journal was discussing the the authors, a group led by Dick Swaab of the Netherlands Institute for Neuroscience in Amsterdam. 

Continue reading Article on sexual orientation and psych disorders retracted – without the author’s knowledge, he says

Cancer researcher banned from federal funding for faking data in nearly 400 images in 16 grant applications

A former associate professor at Purdue University faked data in two published papers and hundreds of images in 16 grant applications, according to a U.S. government research watchdog. 

Alice C. Chang, whose publications and grants listed her name as Chun-Ju Chang, received nearly $700,000 in funding from the National Institutes of Health (NIH) through grant applications that the U.S. Office of Research Integrity (ORI) said contained fake data. She will be banned from receiving federal grants for a decade – a more severe sanction than ORI has typically imposed in recent years.

In its findings, ORI said Chang, who was an associate professor of basic medical sciences at Purdue’s College of Veterinary Medicine:

Continue reading Cancer researcher banned from federal funding for faking data in nearly 400 images in 16 grant applications

PLOS flags nearly 50 papers by controversial French COVID researcher for ethics concerns

Didier Raoult

The publisher PLOS is marking nearly 50 articles by Didier Raoult, the French scientist who became controversial for promoting hydroxychloroquine for treating COVID-19, with expressions of concern while it investigates potential research ethics violations in the work. 

PLOS has been looking into more than 100 articles by Raoult, but determined that the issues in 49 of the papers, including reuse of ethics approval reference numbers, warrant expressions of concern while the publisher continues its inquiry. 

In August of 2021, scientific sleuth Elisabeth Bik wrote on her blog about a series of 17 articles from IHU-Méditerranée Infection that described different studies involving homeless people in Marseille over a decade, but all listed the same institutional ethics approval number. One of those papers, “Distinguishing Body Lice from Head Lice by Multiplex Real-Time PCR Analysis of the Phum_PHUM540560 Gene,” about which Bik also posted on PubPeer, was published in PLOS ONE in 2013, and is receiving an expression of concern today. 

Continue reading PLOS flags nearly 50 papers by controversial French COVID researcher for ethics concerns

Professor emeritus loses fourth paper after UCSF-VA investigation, five years after other retractions

Rajvir Dahiya

A former research center director and professor emeritus of urology has lost a fourth paper after a joint investigation by the University of California San Francisco and the San Francisco Veterans Affairs Medical Center found faked data in several of his articles. 

The other three retractions for Rajvir Dahiya, who directed the UCSF/VAMC Urology Research Center from 1991 until his retirement in 2020, date from 2017. In addition, a paper of his in the Proceedings of the National Academy of Sciences was corrected in 2018, and one in Clinical Cancer Research received an expression of concern last year. 

The latest retraction is for “Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity,” published in Oncogene in 2007. It has been cited 191 times, according to Clarivate’s Web of Science. 

The retraction note, like some of the other editorial notes for Dahiya’s papers, cites the findings of a joint investigation by UCSF and the VA Medical Center: 

Continue reading Professor emeritus loses fourth paper after UCSF-VA investigation, five years after other retractions

Board members decry their own journal’s retraction of paper on predatory publishers

Academics affiliated with a journal that retracted a paper on predatory publishing last year — after one of the publishers mentioned in the analysis complained — have put out a letter critiquing the decision, saying the retraction “lacks justification.” 

The authors of the retracted article appealed the decision to the Committee on Publication Ethics (COPE), but lost. They republished their work in another journal last month.

As we reported last September, the Springer Nature journal Scientometrics retracted “Predatory publishing in Scopus: evidence on cross-country differences,” after receiving a letter from Fred Fenter, chief executive editor of Frontiers, one of the publishers included in the analysis, demanding the paper’s “swift retraction.” His key complaint: the article’s reliance on librarian Jeffrey Beall’s now-defunct list of allegedly predatory publishers. 

Continue reading Board members decry their own journal’s retraction of paper on predatory publishers

Paper about “sexual intent” of women wearing red retracted seven years after sleuths raised concerns

Nicolas Guéguen

A psychologist whose controversial publications on human behavior have attracted scrutiny for their implausible workload and impossible statistics has lost a third paper – seven years after sleuths first began questioning it. 

The 2012 article, “Color and Women Attractiveness: When Red Clothed Women Are Perceived to Have More Intense Sexual Intent,” was published in the Journal of Social Psychology, a Taylor & Francis title. It has been cited 53 times, according to Clarivate’s Web of Science. 

Nicolas Guéguen of the Université de Bretagne-Sud in France is listed as the paper’s sole author. We’ll let him describe the article, as he did in its abstract: 

Continue reading Paper about “sexual intent” of women wearing red retracted seven years after sleuths raised concerns

Buzzy Lancet long COVID paper under investigation for ‘data errors’

An early and influential paper on long COVID that appeared in The Lancet has been flagged with an expression of concern while the journal investigates “data errors” brought to light by a reader. 

An editorial that accompanied the paper when it was published in January of last year described it as “the first large cohort study with 6-months’ follow-up” of people hospitalized with COVID-19. The article has received plenty of attention since then. 

Titled “6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,” the paper has been cited nearly 1,600 times, according to Clarivate’s Web of Science. Altmetric finds references to it in multiple documents from the World Health Organization.  

Continue reading Buzzy Lancet long COVID paper under investigation for ‘data errors’

Psychologists want to retract old papers about conversion therapy. Elsevier says no.

Over the past year, a professional society for cognitive therapists has been pondering what to do with dozens of decades-old articles about conversion therapy – the practice of trying to change a person’s sexual orientation or gender identity – in the archives of the journals it publishes. 

The society, the Association for Behavioral and Cognitive Therapies (ABCT), was considering a variety of options, including retraction. 

But in a statement the group published earlier this month, ABCT said Elsevier, the journals’ publisher, would not allow retraction of the articles. 

Continue reading Psychologists want to retract old papers about conversion therapy. Elsevier says no.